e-learning
resources
ERJ
2003
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Epoprostenol therapy for primary pulmonary hypertension after rejection of a single donor lung
Roeleveld R.J., Vonk Noordegraaf A., van der Bij W., Postmus P.E., Boonstra A.
Source:
Eur Respir J 2003; 21: 192-194
Journal Issue:
January
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Roeleveld R.J., Vonk Noordegraaf A., van der Bij W., Postmus P.E., Boonstra A.. Epoprostenol therapy for primary pulmonary hypertension after rejection of a single donor lung. Eur Respir J 2003; 21: 192-194
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Should we screen for hereditary pulmonary hypertension?
Patient with ankylosing spondylitis and pulmonary hypertension
Related content which might interest you:
Cautious epoprostenol therapy is a safe bridge to lung transplantation in pulmonary veno-occlusive disease
Source: Eur Respir J 2009; 34: 1348-1356
Year: 2009
Is sildenafil an effective bridging therapy to lung transplantation for patients with pulmonary hypertension in the setting of lung disease?
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015
Intravenous iloprost bridging to orthotopic liver transplantation in portopulmonary hypertension
Source: Eur Respir J 2004; 24 : 703-707
Year: 2004
Inhaled treprostinil therapy in patients with pulmonary hypertension and parenchymal lung disease
Source: Annual Congress 2011 - Treatment of pulmonary hypertension
Year: 2011
Lung transplantation for pulmonary hypertension
Source: Eur Respir Mon 2012; 57: 247-255
Year: 2012
Risk stratification in patients with pulmonary arterial hypertension (PAH) and candidates for lung or heart-lung transplantation
Source: Virtual Congress 2021 – All about pulmonary arterial hypertension
Year: 2021
Management of end-stage sarcoidosis: pulmonary hypertension and lung transplantation
Source: Eur Respir J 2012; 39: 1520-1533
Year: 2012
Continuous intravenous epoprostenol for chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2004; 23: 595-600
Year: 2004
Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant
Source: Eur Respir J 2007; 30: 715-721
Year: 2007
Impact of pulmonary hypertension after lung transplantation on functional outcome
Source: Annual Congress 2010 - Pre-operative evaluation and post-operative problems after lung transplantation
Year: 2010
The management of patients awaiting lung transplantation
Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=16
Year: 2003
Lung transplantation for pulmonary arterial hypertension
Source: International Congress 2015 – Lung transplantation in the year 2015: current indications and results
Year: 2015
Prognosis in patients with primary pulmonary hypertension awaiting lung transplantion
Source: Eur Respir J 2001; 18: Suppl. 33, 297s
Year: 2001
Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil
Source: Eur Respir J 2006; 28: 1195-1203
Year: 2006
Inhaled iloprost for patients with pulmonary arterial hypertension and right heart failure
Source: Annual Congress 2010 - Pulmonary circulation I
Year: 2010
Sitaxentan-related acute liver failure in a patient with pulmonary arterial hypertension
Source: Eur Respir J 2011; 37: 472
Year: 2011
Treatment of pulmonary hypertension in chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=313
Year: 2006
Time-course changes in pulmonary haemodynamics in patients with idiopathic pulmonary fibrosis (IPF) waiting for lung transplantation (LT)
Source: Eur Respir J 2004; 24: Suppl. 48, 668s
Year: 2004
Long-term treatment of pulmonary hypertension with aerosolized iloprost
Source: Eur Respir J 2001; 17: 8-13
Year: 2001
New issues in lung transplantation for pulmonary hypertension
Source: Virtual Congress 2020 – Lung transplantation in the era of new drugs
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept